Kinnevik’s Year-End Release 2025
“In 2025, we sharpened our focus on developing a stable, more mature, and more profitable portfolio. While our companies’ operational performance was solid on aggregate, net asset value creation was negatively affected by a decline in comparable public market multiples and adverse currency movements. Disappointing developments in Climate Tech also weighed on our performance. Meanwhile, we saw large funding rounds at Perk, Mews and Enveda - all at meaningful premiums to our NAV. We selectively added new investments in our focus sectors through the year and accelerated the maturing of our portfolio by investing USD 100m in new core company Oviva - a leading profitable European digital health platform for weight-related and chronic illnesses.”
Georgi Ganev, CEO of Kinnevik
Events of the Quarter
Events After the End of the Quarter
Events of the Full-Year 2025
Capital Reallocation
Financial Position
Organization
A conference call will be held today at 10.00 CET to present the results. The conference call will be held in English. Those who wish to participate and ask questions during the conference call are welcome to register via the link below. Participants will receive dial-in numbers and confirmation code upon registration. Please make sure to register and dial in a few minutes before the call begins.
This information is information that Kinnevik AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (596/2014). The information was submitted for publication, through the agency of the contact person set out below, at 2026-02-03 08:00 CET.
For further information, visit www.kinnevik.com or contact:
Mikaela Kramer, Corporate Communications & Sustainability Manager
Phone: +46 (0)70 762 00 50
Email: press@kinnevik.com
Kinnevik is a leading growth investor on a mission to redefine industries and create remarkable growth companies. We are an active owner and operational partner, providing patient capital to challenger technology-enabled businesses in Europe and the US. Our passionate founders are building tomorrow’s leaders within healthcare, software and climate, making everyday life easier and better for people around the world. We invest at all stages of a company’s growth journey, always determined to create long-term value. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.